期刊文献+

尿路感染细菌分布及细菌耐药性分析 被引量:66

Bacteria Distribution and Antibiotic Resistance Analysis of Urinary Tract Infection in 2004
下载PDF
导出
摘要 目的 调查了解2004年尿路感染病原菌的分布及耐药情况,为临床提供可靠的诊断和治疗依据。方法 对2004年1月1日~2004年12月31日间,北京医院住院及门诊患者1007份尿培养标本及其分离出的632株细菌进行鉴定和耐药分析。结果 2004年尿路感染菌株以大肠埃希菌为主,占38.29%;其次为肠球菌属(18.67%)、念珠菌属(17.41%)、链球菌属(8.07%)、变形菌属(3.4%)、葡萄球菌属(3.95%)、铜绿假单胞菌(3.17%)及肺炎克雷伯菌(2.37%);肠杆菌科细菌对亚胺培南保持100%敏感;呋喃妥因和万古霉素对革兰阳性球菌敏感率较高;真菌感染的发生率较2001年有明显上升趋势。结论 2004年尿路感染的主要致病菌仍是肠杆菌属,并以大肠埃希氏菌为主;真菌感染旱明显上升趋势。应高度重视。 OBJECTIVE To investigate the bacteria distribution and antibiotic resistance in urinary tract infection in 2004. METHODS During Jan 1st 2004 to Dec 31st 2004, 1007 urine specimens were collected from inpatient and outpatient departments of Beijing Hospital. Totally 632 strains of pathogens were identified and the drug resistance was performed. RESULTS Among pathogens of urinary tract infection in 2004, Escherichia coli rated the first (38. 29%), followed by Enterococcus (18.67%), fungi (17. 41%), Streptococcus (8. 07%), Proteus (3.4%), Staphylococcus (3.95 %), Pseudomonas aeruginosa (3.17 %) and Klebsiella pneumoniae (2.37 %). Enterobacteriaceae were sensitive to imipenem (100%). G^+ cocci were sensitive to nitrofurantoin and vancomycin (nearly to 100%). Compared to pathogens of UTI in 2001, fungi showed obviously increasing trend. CONCLUSIONS In 2004, Enterobaeteriaeeae (mostly E. coli) are the major pathogens in urinary tract infection. Fungi infection in urinary tract has an obviously increasing tendency and should be carefully treated.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2006年第3期345-347,共3页 Chinese Journal of Nosocomiology
关键词 尿路感染 病原菌 抗菌药物 耐药性 Urinary tract infection Pathogens Antibiotics Drug resistance
  • 相关文献

参考文献5

二级参考文献24

  • 1叶元康 王慕娣.新支原体成品培养基的研究[J].中华流行病学杂志,1998,19(3):222-222.
  • 2沈蓓琼 徐菲 等.泌尿生殖道支原体感染及解脲脲原体耐药性分析[J].临床检验杂志,1999,17(5):268-268.
  • 3National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[S].Ninth Informatioal Supplement.NCCLS document M 100-S9.
  • 4CDC.Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States 1997[J].MMWR, 1997, 46: 813-815.
  • 5Murray BE.Vancomycin-resistant enterococci[J].Am J Med, 1997, 102: 284.
  • 6萨姆布鲁克 J, 弗里奇 EF, 曼尼阿蒂斯 T(金冬雁,黎孟枫,译). 分子克隆实验指南[M]. 第2版,北京: 科学出版社, 1999.10
  • 7Yano H, Kuga A, Irinoda K, et al. Presence of genes for β-lactam ases of two d ifferent classes on a single plasmid from a clinical isolates of Serratia marces cens[J]. J Antibiot, 1999, 52(12):1135-1139
  • 8中华医院管理学会医院感染管理专业委员会. 医院感染诊断标准[S]. 97'全国医院感染管理学术会议论文集[C],1997, 24-29
  • 9Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases[J]. Antibimic rob Agents Chemother,1991,35(9): 1697-1704
  • 10National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susc eptibility testing:ninth informational supplement[S]. NCCLS, 1999, 19(1): 36, 75

共引文献229

同被引文献261

引证文献66

二级引证文献334

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部